Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02742922Not ApplicableCompleted

Multicenter Study to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP)

Role: collaborator

NCT04347499Not ApplicableCompleted

Culturally Adapted CBT Based Guided Self-Help in Patients With Postnatal Depression

Role: lead

NCT04347525Not ApplicableCompleted

The Effect of Culturally Adapted CBT-based Guided Self Help in Depressed Patients With Myocardial Infarction

Role: lead

NCT01908114Phase 4Unknown

To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan

Role: collaborator

NCT02797691Not ApplicableCompleted

Developing and Testing of Culturally Adapted Cognitive Behavior Therapy (CaCBT) for Pashto Speaking Pakistanis and Afghans

Role: lead

All 5 trials loaded